GCTK Short Volume
GlucoTrack, Inc. (GCTK) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $2.2M, listed on NASDAQ, employing roughly 15 people, carrying a beta of 0.66 to the broader market. Based in Or Yehuda, Israel, GlucoTrack, Inc. Led by Erik Emerson, public since 2013-04-25.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 131.3K
- Total Volume
- 294.9K
- Short %
- 44.53%
- 30-Day Avg Short %
- 38.10%
Showing 30 days of FINRA short volume data for GlucoTrack, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked GCTK short volume questions
- What is the daily GCTK short volume?
- As of Aug 28, 2026, GlucoTrack, Inc. (GCTK) short volume is 131.3K shares against 294.9K total reported volume, or 44.53% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is GCTK short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does GCTK short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.